Coherus Biosciences Inc
Company Overview
Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative immunotherapy products. The company specializes in biosimilars and immuno-oncology treatments, with a portfolio that includes both marketed products and candidates in development.
The company's business model revolves around developing, manufacturing, and commercializing high-quality, cost-effective medicines that improve patient access to important therapies. Their primary focus is on oncology and inflammatory diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $70.77m | $82.52m | - | $5.36m | 0.00% | 6.50% |
| June 30, 2024 | $64.98m | $103.45m | - | $17.96m | 0.00% | 17.36% |
| March 31, 2024 | $77.06m | $130.7m | - | $11.12m | 0.00% | 8.50% |
Company Impact
Help us evaluate Coherus Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.